Impact of Aerobic Exercise Training on Age-Related Changes in Insulin Sensitivity and Muscle Oxidative Capacity
- Kevin R. Short1,
- Janet L. Vittone2,
- Maureen L. Bigelow1,
- David N. Proctor3,
- Robert A. Rizza1,
- Jill M. Coenen-Schimke1 and
- K. Sreekumaran Nair1
- 1Department of Internal Medicine, Division of Endocrinology, Mayo Clinic, Rochester, Minnesota
- 2Department of General Internal Medicine, Mayo Clinic, Rochester, Minnesota
- 3Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota
- Address correspondence and reprint requests to K. Sreekumaran Nair, PhD, Endocrinology Research Unit, 5–194 Joseph, Mayo Clinic, 200 First St. SW, Rochester, MN 55905. E-mail: nair.sree{at}mayo.edu
Abstract
Insulin resistance increases and muscle oxidative capacity decreases during aging, but lifestyle changes—especially physical activity—may reverse these trends. Here we report the effect of a 16-week aerobic exercise program (n = 65) or control activity (n = 37) performed by men and women aged 21–87 years on insulin sensitivity and muscle mitochondria. Insulin sensitivity, measured by intravenous glucose tolerance test, decreased with age (r = −0.32) and was related to abdominal fat content (r = −0.65). Exercise increased peak oxygen uptake (Vo2peak; 10%), activity of muscle mitochondrial enzymes (citrate synthase and cytochrome c oxidase, 45–76%) and mRNA levels of mitochondrial genes (COX4, ND4, both 66%) and genes involved in mitochondrial biogenesis (PGC-1α, 55%; NRF-1, 15%; TFAM, 85%). Exercise also increased muscle GLUT4 mRNA and protein (30–52%) and reduced abdominal fat (5%) and plasma triglycerides (25%). None of these changes were affected by age. In contrast, insulin sensitivity improved in younger people but not in middle-aged or older groups. Thus, the muscle mitochondrial response to 4 months of aerobic exercise training was similar in all age-groups, although the older people did not have an improvement in insulin sensitivity.
- GCRC, General Clinical Research Center
- NRF, nuclear respiratory factor
- PGC-1α, PPAR-γ coactivator 1α
- PPAR, peroxisome proliferator–activated receptor
- TFAM, mitochondrial transcription factor A
- Vo2peak, peak oxygen uptake
- SI, insulin sensitivity
Footnotes
-
- Accepted May 1, 2003.
- Received October 31, 2002.
- Revision received May 1, 2003.
- DIABETES














